Toward a standard clinicopathologic staging approach for differentiated thyroid carcinoma

Seminars in Surgical Oncology

Volumn 16, Issue 1, 1999, Pages 12-15

  Sherman, Steven I ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Follicular adcnocarcinoma; Mortality; Neoplasm metastasis; Neoplasm staging; Papillary carcinoma; Prognosis; Risk factors; Thyroid neoplasms

Indexed keywords

CANCER CLASSIFICATION; CANCER RISK; CANCER STAGING; METASTASIS; MORTALITY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; STANDARDIZATION; THYROID CANCER;

CARCINOMA; HUMANS; MIDDLE AGED; THYROID NEOPLASMS;

EID: 0031752735     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-2388(199901/02)16:1<12::aid-ssu3>3.0.co;2-m     Document Type: Article

References (25)

1. Hermanek P, Sobin LH, Fleming ID: What do we need beyondTNM? [editorial]. Cancer 1996;77:815-817.
2. Fielding LP, Fenoglio-Preiser CM, Freedman LS: The future of prognostic factors in outcome prediction for patients with cancer [Review]. Cancer 1992;70:2367-2377.
3. Hermanek P, Sobin LH (eds): 'TNM classification of malignant tumours." 5th ed. New York: Wiley-Liss; 1992.
4. Brierley JD, Panzarella T, Tsang R\V, et al: A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma is an example [Review]. Cancer 1997;79: 2414-2423.
5. Byar DP, Green SB, Dor P, et al: A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. thyroid cancer cooperative group. Eur J Cancer 1979;15:1033-1041.
6. American Joint Commission on Cancer. "AJCC cancer staging manual." 5th ed. Philadelphia: Lippincott-Raven; 1997.
7. Cady B, Rossi R: An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988; 104:947-953.
8. Mazzaferri EL, Jhiang SM: Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer [published erratum in Am J Med 1995;98:215] [comment in: Am J Med 1994;97:499-500]. Am J Med 1994;97:418-428.
9. DeGroot LJ, Kaplan EL, McCormick M, Straus FH: Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:414-424.
10. Hay ID, Bergstralh El, Goellner JR, et al: Predicting outcome in papillary carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;! 14:1050-1058.
11. Mannequin P, Liehn JC, Delisle MJ: Multifactorial analysis of survival in thyroid cancer. Pitfalls of applying the results of published studies to another population. Cancer 1986;98:1749-1755.
12. Cady B: Staging in thyroid cancer [editorial]. Cancer 1998; 83: 844-847.
13. Samaan NA, Schultz PN, Hickey RC, et al: The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1,599 patients. J Clin Endocrinol Metab 1992;75:714-720.
14. DeGroot LJ, Kaplan EL, Straus FH, Shukla MS: Does the method of management of papillary thyroid carcinoma make a difference in outcome? World J Surg 1994;18:123-130.
15. Hay ID: Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990;19:545-576.
16. Hay ID, Grant CS, Taylor WF, McConahey WM: Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088-1095.
17. Davis NL, Bugis SP, McGregor GI, Germann E. An evaluation of prognostic scoring systems in patients with follicular thyroid cancer. Am J Surg 1995;170:476-480.
18. DeGroot LJ, Kaplan EL, Shukla MS, et al: Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab 1995;80:29462953.
19. Sherman SI, Brierley JD, Sperling M, et al: Prospective multicenter study of treatment of thyroid carcinoma: initial analysis of staging and outcome. Cancer 1998; 83:1012-1021.
20. Robbins J, Merino MJ, Boice JD Jr, et al: Thyroid cancer: a lethal endocrine neoplasm [Review]. Ann Intern Med 1991 ; 115:133-147.
21. Grossman RF, Tu SH, Dun QY, et al: Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment [Review] [comment in Arch Surg 1996;131:676]. Arch Surg 1995;130:892-899.
22. Chiu AC, Delpassand ES, Sherman SI: Prognosis and treatment of brain métastases in thyroid carcinoma. J Clin Endocrinol Metab 1997;82:3637-3642.
23. Tallin! G, Ghossein R, Emanuel J, et al: Detection of thyroglobulin and thyroid peroxidase mRNA in the peripheral blood of patients with thyroid disease. Thyroid 1996;6:S29.
24. Korn EL, Simon R: Measures of explained variation for survival data. Stat Med 1990;9:487-503.
25. Schemper M: The relative importance of prognostic factors in studies of survival. Stat Med 1993; 12:2377-2382.